Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Sales | 1,224 | 363 | 18,411 | 21,434 | 922 |
| Gross Profit | 1,224 | 363 | 18,411 | 21,434 | 922 |
| Operating Expenses | 69,925 | 64,544 | 71,342 | 72,321 | 56,760 |
| Operating Income | -68,701 | -64,181 | -52,931 | -50,887 | -55,838 |
| Interest Expense | 1,484 | 46 | 89 | 148 | 260 |
| Other Income | 146 | 1,082 | 990 | 2,994 | 23 |
| Pre-tax Income | -70,039 | -63,145 | -52,030 | -48,041 | -56,075 |
| Income Tax | -1,113 | -3,512 | -3,245 | -3,629 | -1,139 |
| Net Income Continuous | -68,926 | -59,633 | -48,785 | -44,412 | -54,936 |
| Net Income | $-68,926 | $-59,633 | $-48,785 | $-44,412 | $-54,936 |
| EPS Basic Total Ops | -0.93 | -1.16 | -1.07 | -1.28 | -1.98 |
| EPS Basic Continuous Ops | -0.93 | -1.16 | -1.07 | -1.28 | -1.98 |
| EPS Diluted Total Ops | -0.93 | -1.16 | -1.07 | -1.28 | -1.98 |
| EPS Diluted Continuous Ops | -0.93 | -1.16 | -1.07 | -1.28 | -1.98 |
| EBITDA(a) | $-67,154 | $-62,462 | $-51,226 | $-49,302 | $-53,780 |